DESCRIPTION
PT-141, also known as Bremelanotide, is a single-component research peptide supplied exclusively for controlled laboratory research environments. This lyophilized research material is intended for non-clinical applications involving peptide characterization, analytical method development, and experimental evaluation of melanocortin receptor pathways in laboratory model systems.
COMPOSITION
• PT-141 (Bremelanotide): 10 mg
• Appearance: Lyophilized powder in a sealed research vial
RESEARCH FOCUS (NON-CLINICAL)
• Peptide identity and purity assessment
• Analytical assay development and quantitative method validation
• Evaluation of melanocortin receptor pathway activity in laboratory model systems
• Chromatographic method optimization for impurity profiling and peak resolution
• Stability characterization under laboratory storage conditions
DOCUMENTATION
• Lot-specific Certificate of Analysis (COA)
• Batch and lot traceability
• QR code access to product documentation
• Manufacturing quality documentation
IMPORTANT NOTICE
• For research use only
• Not for human consumption
• Not intended for diagnostic, therapeutic, veterinary, or clinical use
• Not intended to diagnose, treat, cure, or prevent any disease
QUALITY & MANUFACTURING
• Manufactured in the USA in an ISO 9001-based, cGMP-aligned facility
• Third-party tested with a lot-specific Certificate of Analysis
• Lyophilized for laboratory stability and secure transit
• Tamper-evident seal with printed lot number and test date
• Each lot documented throughout production
